London — Johnson & Johnson (J&J) is preparing to test an experimental HIV vaccine in the US and Europe in a move toward developing the first immunisation against the deadly disease after decades of frustration.

About 3,800 men who have sex with men will receive a regimen of shots in a study that’s planned to be launched later in 2019, Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, said in an interview. The agency and the HIV Vaccine Trials Network of testing sites will collaborate with J&J’s Janssen unit on the effort.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now